AQR Capital Management LLC cut its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 25.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,455 shares of the technology company’s stock after selling 2,941 shares during the quarter. AQR Capital Management LLC’s holdings in Simulations Plus were worth $411,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in the stock. Silvercrest Asset Management Group LLC acquired a new position in shares of Simulations Plus in the first quarter worth approximately $4,717,000. Wasatch Advisors LP boosted its stake in shares of Simulations Plus by 36.5% in the 1st quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock valued at $15,707,000 after purchasing an additional 102,135 shares during the last quarter. Congress Asset Management Co. MA increased its position in shares of Simulations Plus by 34.6% during the first quarter. Congress Asset Management Co. MA now owns 171,490 shares of the technology company’s stock worth $7,057,000 after buying an additional 44,129 shares during the period. Dimensional Fund Advisors LP raised its stake in Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after buying an additional 37,992 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in Simulations Plus in the second quarter valued at $1,320,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.
Simulations Plus Price Performance
NASDAQ SLP opened at $31.50 on Wednesday. The company’s 50 day simple moving average is $33.65 and its two-hundred day simple moving average is $41.18. The stock has a market capitalization of $630.25 million, a PE ratio of 65.63 and a beta of 0.69. Simulations Plus, Inc. has a 1 year low of $29.37 and a 1 year high of $51.22.
Analysts Set New Price Targets
Read Our Latest Report on Simulations Plus
Insider Transactions at Simulations Plus
In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $35.18, for a total value of $703,600.00. Following the completion of the sale, the director now owns 3,501,592 shares of the company’s stock, valued at approximately $123,186,006.56. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders sold 60,750 shares of company stock worth $2,145,055. 20.90% of the stock is currently owned by corporate insiders.
Simulations Plus Profile
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles
- Five stocks we like better than Simulations Plus
- What Do S&P 500 Stocks Tell Investors About the Market?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- How Can Investors Benefit From After-Hours Trading
- AMD Gains Momentum With AI: Can It Beat Expectations?
- How to Invest in the Best Canadian StocksĀ
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.